BioSpace News Archive

Business

Neurocrine Biosciences and Jnana Therapeutics Enter Strategic Collaboration to Discover Novel Medicines to Treat Central Nervous System Disorders

Partnership Leverages Neurocrine’s Expertise in Neuroscience and Jnana’s Proprietary Drug Discovery Platform Targeting the Solute Carrier Family of Transporters

October 9, 2018
·
5 min read
Business

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 6, 2018

Novanta Inc. will release its third quarter 2018 results on Tuesday, November 6, 2018.

October 9, 2018
·
1 min read
Pharm Country

Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Hurricane Michael

Dentists, Physicians, and Veterinarians Who May Experience Operational, Logistical, or Financial Issues Encouraged to Call 800-999-9729

October 9, 2018
·
3 min read
Business

Cerus Appoints Eric Bjerkholt to Board of Directors

Cerus Corporation today announced the appointment of Eric Bjerkholt to its Board of Directors.

October 9, 2018
·
2 min read
Biotech Bay

New NCCN Breast Cancer Guidelines Elevate Oncotype DX Breast Recurrence Score® as the Only Preferred Multi-gene Test to Predict Chemotherapy Treatment

Updated NCCN Guidelines Underscore the Unique Advantage of the Oncotype DX® Test in Predicting Chemotherapy Benefit

October 9, 2018
·
5 min read
Genetown

Akebia Therapeutics Announces Presentations at the American Society of Nephrology Kidney Week 2018 Annual Meeting

Akebia Therapeutics, Inc. today announced two posters to be presented at the upcoming American Society of Nephrology Kidney Week 2018 Annual Meeting in San Diego, California, from October 23 to 28, 2018.

October 9, 2018
·
2 min read
Biotech Bay

Veracyte Announces Presentation of “Real World” Clinical Utility Data at CHEST 2018 Showing Percepta Classifier Reduces Invasive Procedures in Lung Cancer Diagnosis

Preliminary data from ongoing, three-year registry study demonstrate that reduction in potentially harmful invasive procedures extends for first 12 months post-test

October 9, 2018
·
7 min read
Deals

Audentes Therapeutics Announces Proposed Public Offering of $150 Million of Its Common Stock

Audentes Therapeutics, Inc. announced today that it intends to offer $150 million of its common stock in an underwritten public offering.

October 9, 2018
·
3 min read
Business

Healthcare Trust of America, Inc. Sets Dates to Report 2018 Third Quarter Financial Results and Host Conference Call

Healthcare Trust of America, Inc. announced today that on Thursday, October 25, 2018, after the market closes, HTA will report its financial results for the three months ending September 30, 2018.

October 9, 2018
·
5 min read
Business

Illumina to Announce Third Quarter 2018 Financial Results on Tuesday, October 23, 2018

Illumina, Inc. today announced that it will issue results for third quarter 2018 following the close of market on Tuesday, October 23, 2018.

October 9, 2018
·
1 min read